Characterization of human trophoblast as a mineralocorticoid target tissue

Molecular Human Reproduction

Volumn 9, Issue 12, 2003, Pages 793-798

  Driver, P M ^a   Rauz, S ^a   Walker, E A ^a   Hewison, M ^a   Kilby, M D ^a   Stewart, P M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cytotrophoblasts; Mineralocorticoid receptor; Serum and glucocorticoid inducible kinase; Trophoblast

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; HYDROCORTISONE; MIFEPRISTONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; SODIUM CHANNEL;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTROPHOBLAST; EMBRYO; ENZYME SUBUNIT; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS GROWTH; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCORTISOLISM; INHIBITION KINETICS; MODULATION; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM TRANSPORT; TARGET ORGAN; TROPHOBLAST;

ADULT; EPITHELIAL SODIUM CHANNEL; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; MINERALOCORTICOIDS; NA(+)-K(+)-EXCHANGING ATPASE; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SODIUM CHANNELS; TROPHOBLASTS;

EID: 0345327653     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gag091     Document Type: Article

References (42)

1. Arriza, J.L., Simerly, R.B., Swanson, L.W. and Evans, R.M. (1988) The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron, 1, 887-900.
2. Barker, D.J., Osmond, C., Golding, J., Kuh, D. and Wadsworth, M.E. (1989a) Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br. Med. J., 298, 564-567.
3. Barker, D.J., Winter, P.D., Osmond, C., Margetts, B. and Simmonds, S.J. (1989b) Weight in infancy and death from ischaemic heart disease. Lancet, 2, 577-580.
4. Baxendale-Cox, L.M., Duncan, R.L., Liu, X., Baldwin, K., Els, W.J. and Helman, S.I. (1997) Steroid hormone-dependent expression of blocker-sensitive ENaCs in apical membranes of A6 epithelia. Am. J. Physiol., 273, C1650-C1656.
5. Brown, R.W., Chapman, K.E., Edwards, C.R. and Seckl, J.R. (1993) Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. Endocrinology, 132, 2614-2621.
6. Chen, S.Y. et al. (1999) Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc. Natl Acad. Sci. USA, 96, 2514-2519.
7. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium, thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
8. Clarson, L.H., Glazier, J.D., Greenwood, S.L., Jones, C.J., Sides, M.K. and Sibley, C.P. (1996) Activity and expression of Na(+)-K(+)-ATPase in human placental cytotrophoblast cells in culture. J. Physiol., 497, 735-743.
9. Condon, J. et al. (1998) Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J. Clin. Endocrinol. Metab., 83, 4490-4497.
10. Denault, D.L., Fejes-Toth, G. and Naray-Fejes-Toth, A. (1996) Aldosterone regulation of sodium channel gamma-subunit mRNA in cortical collecting duct cells. Am. J. Physiol., 271, C423-C428.
11. Driver, P.M., Kilby, M.D., Bujalska, I., Walker, E.A., Hewison, M. and Stewart, P.M. (2001) Expression of 11 beta-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies. Mol. Hum. Reprod., 7, 357-363.
12. Edwards, C.R. et al. (1988) Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet, 2, 986-989.
13. Edwards, C.R., Benediktsson, R., Lindsay, R.S. and Seckl, J.R. (1993) Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet, 341, 355-357.
14. Escoubet, B., Coureau, C., Bonvalet, J.P. and Farman, N. (1997) Noncoordinate regulation of epithelial Na channel and Na pump subunit mRNAs in kidney and colon by aldosterone. Am. J. Physiol., 272, C1482-C1491.
15. Funder, J.W., Pearce, P.T., Smith, R. and Smith, A.I. (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science, 242, 583-585.
16. + channel by aldosterone: open questions and emerging answers. Kidney Int., 57, 1270-1276.
17. Geller, D.S. et al. (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science, 289, 119-123.
18. Greenwood, S.L., Boyd, R.D. and Sibley, C.P. (1993) Transtrophoblast and microvillus membrane potential difference in mature intermediate human placental villi. Am. J. Physiol., 265, C460-C466.
19. Hales, C.N. et al. (1991) Fetal and infant growth and impaired glucose tolerance at age 64. Br. Med. J., 303, 1019-1022.
20. Hirasawa, G. et al. (2000) 11Beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta. J. Clin. Endocrinol. Metab., 85, 1306-1309.
21. Kitanaka, S., Tanae, A. and Hibi, I. (1996) Apparent mineralocorticoid excess due to 11 beta-hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation. Clin. Endocrinol., 44, 353-359.
22. Kliman, H.J., Nestler, J.E., Sermasi, E., Sanger, J.M. and Strauss, J.F., III (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology, 118, 1567-1582.
23. McTernan, C.L. et al. (2001) Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J. Clin. Endocrinol. Metab., 86, 4979-4983.
24. Milford, D.V., Shackleton, C.H. and Stewart, P.M. (1995) Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. Clin. Endocrinol., 43, 241-246.
25. Mujais, S.K., Chekal, M.A., Jones, W.J., Hayslett, J.P. and Katz, A.I. (1984) Regulation of renal Na-K-ATPase in the rat. Role of the natural mine. J. Clin. Invest., 73, 13-19.
26. Osinski, P.A. (1960) Steroid 11b-ol dehydrogenase in human placenta. Nature, 187, 777.
27. Patel, F.A., Sun, K. and Challis, J.R. (1999) Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells. J. Clin. Endocrinol. Metab., 84, 395-400.
28. Pepe, G.J. and Albrecht, E.D. (1990) Regulation of the primate fetal adrenal cortex. Endocr. Rev., 11, 151-176.
29. Pepe, G.J., Burch, M.G. and Albrecht, E.D. (1999) Expression of the 11beta-hydroxysteroid dehydrogenase types 1 and 2 proteins in human and baboon placental syncytiotrophoblast. Placenta, 20, 575-582.
30. Pepe, G.J., Burch, M.G. and Albrecht, E.D. (2001) Localization and developmental regulation of 11beta-hydroxysteroid dehydrogenase-1 and -2 in the baboon syncytiotrophoblast. Endocrinology, 142, 68-80.
31. Rogerson, F.M., Kayes, M.K. and White, P.C. (1997) Variation in placental type 2 11b-hydroxysteroid dehydrogenase activity is not related to birth or placental weight. Mol. Cell. Endocrinol., 128, 103-109.
32. Shams, M. et al. (1998) 11β-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum. Reprod., 13, 799-804.
33. + channel by Nedd4 and ubiquitination. Kidney Int., 57, 809-815.
34. Stewart, P.M., Wallace, A.M., Valentino, R., Burt, D., Shackleton, C.H.L. and Edwards, C.R.W. (1987) Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet, ii, 821-824.
35. Stewart, P.M., Murry, B.A. and Mason, J.I. (1994) Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol. Metab., 78, 1529-1532.
36. Stewart, P.M., Rogerson, F.M. and Mason, J.I. (1995) Type 2 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J. Clin. Endocrinol. Metab., 80, 885-890.
37. Stewart, P.M. et al. (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet, 347, 88-91.
38. Stulc, J. (1997) Placental transfer of inorganic ions and water. Physiol. Rev., 77, 805-836.
39. + across the placenta of the anaesthetized rat. J. Physiol., 470, 637-649.
40. Sun, K., Yang, K. and Challis, J.R. (1997) Differential expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. J. Clin. Endocrinol. Metab., 82, 300-305.
41. +-ATPase mRNAs, protein synthesis, and sodium transport in cultured kidney cells. J. Cell Biol., 104, 1231-1237.
42. Whorwood, C.B. and Stewart, P.M. (1995) Transcriptional regulation of Na/K-ATPase by corticosteroids, glycyrrhetinic acid and second messenger pathways in rat kidney epithelial cells. J. Mol. Endocrinol., 15, 93-103.